| Literature DB >> 30235904 |
Juhyun Park1, Dong Hyun Yoon2, Sangjun Yoo3, Sung Yong Cho4, Min Chul Cho5, Ga-Young Han6, Wook Song7,8, Hyeon Jeong9.
Abstract
We evaluated the efficacy of progressive resistance training of the pelvic floor muscle for post-prostatectomy incontinence. In this prospective study, 59 patients who underwent radical prostatectomy were evaluated preoperatively. Continence was sequentially assessed within 2 weeks postoperatively, and an exercise regimen was initiated at 6- and 12-weeks. The primary outcome was continent status and the secondary outcome was changes in muscle strength and endurance after the exercise intervention. Continence was defined as no urine loss in a 1h pad test. A total of 59 patients participated in this study. Six patients dropped out of the study because of non-compliance and orthopedic problems. Of the remaining 53 patients, 31 (58.5%) achieved pad-free continence at 12 weeks postoperatively. The patients were divided into two groups based on their continence status, and no statistically significant difference was observed in age, body mass index, prostate volume, prostate-specific antigen, pathological Gleason score sum, and pathological T stage. Meanwhile, preoperative maximal urethral closure pressure and change in hip extensor muscle strength and endurance during the 12-week exercise program were significantly higher in the continent group. In multivariate analysis, change in hip extensor muscle strength was the only significant parameter predicting achievement of continence status (Odds ratio, 1.039; p = 0.045). The changes in hip extensor muscle strength in the current exercise program was an independent predictor of continence status after radical prostatectomy. A large-scale prospective study on the relationship between extensor muscle strength and urinary incontinence should be explored in future.Entities:
Keywords: incontinence; pelvic floor muscle; prostatectomy; resistance training
Year: 2018 PMID: 30235904 PMCID: PMC6162607 DOI: 10.3390/jcm7090292
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Exercise program protocol. * Contraction for 10 s.
Figure 2Study flow chart for 12-week exercise program.
Patient characteristics according to the achievement of post-exercise continent status.
| Continent Group | Incontinent Group | ||
|---|---|---|---|
| Age (years) | 68.2 ± 6.1 | 68.3 ± 5.1 | 0.899 |
| Preoperative BMI (kg/m2) | 24.8 ± 2.8 | 26.6 ± 9.0 | 0.289 |
| Post-exercise 12-weeks BMI (kg/m2) | 24.5 ± 2.8 | 24.7 ± 3.3 | 0.827 |
| Prostate volume (mL) | 36.4 ± 19.1 | 37.8 ± 23.5 | 0.827 |
| PSA (ng/dL) | 23.6 ± 42.1 | 24.3 ± 42.8 | 0.953 |
| Op methods | 0.601 | ||
| RRP | 17 | 12 | |
| RALP | 14 | 10 | |
| Pathology Gleason Score Sum | 0.812 | ||
| 6 | 5 | 4 | |
| 7 (3 + 4) | 7 | 5 | |
| 7 (4 + 3) | 8 | 8 | |
| 8 | 7 | 4 | |
| 9 | 4 | 1 | |
| Pathologic T stage | 0.219 | ||
| T2 | 20 (64.5%) | 11 (50.0%) | |
| T3 | 11 (35.5%) | 11 (50.0%) | |
| Participation rate (%) | 42.0 ± 38.7 | 50.4 ± 36.0 | 0.428 |
| Preoperative MUCP (cmH2O) | 78.2 ± 18.8 | 64.8 ± 25.3 | 0.036 |
| Preoperative MCC (mL) | 355.3 ± 133.1 | 339.4 ± 139.2 | 0.685 |
| Preoperative PdetQmax (cm H2O) | 55.1 ± 21.0 | 48.7 ± 20.2 | 0.285 |
| Post-exercise 12-week MUCP (cm H2O) | 56.1 ± 25.3 | 53.6 ± 27.0 | 0.739 |
| Post-exercise 12-week MCC (mL) | 339.5 ± 89.7 | 297.1 ± 77.3 | 0.085 |
| Post-exercise 12-week DetQmax (cm H2O) | 38.5 ± 18.5 | 30.6 ± 15.6 | 0.123 |
| Change of MUCP (cm H2O) | 24.4 ± 29.4 | 12.9 ± 30.6 | 0.199 |
| Post-exercise 6-week pad (g) | 14.2 ± 45.6 | 18.7 ± 23.8 | 0.676 |
| Post-exercise 6-week pad number | 1.67 ± 2.1 | 4.2 ± 5.8 | 0.034 |
| Post-exercise 12-week pad (g) | 0 | 14.7 ± 25.1 | 0.002 |
| Post-exercise 12-week pad number | 0.4 ± 0.5 | 2.14 ± 2.4 | <0.001 |
BMI, Body mass index; PSA, prostate-specific antigen; RRP, retropubic radial prostatectomy; RALP, robot-assisted laparoscopic radical prostatectomy; MUCP, Maximal urethra closure pressure; MCC, maximal cystometric capacity; PdetQmax, detrusor pressure at maximal urinary flow in pressure-flow study.
Change of pelvic muscle strength and endurance according to the achievement of post-exercise continent status.
| Continent Group | Incontinent Group | ||||
|---|---|---|---|---|---|
| Pre | Post | Pre | Post | ||
|
| |||||
|
| |||||
| Pre/Post exercise muscle strength | 119.5 + 41.7 | 145.9 + 41.3 | 138.0 + 67.5 | 139.6 + 55.4 | |
| Change of muscle strength | 22.3 ± 39.7 | −9.5 ± 32.4 | 0.005 | ||
|
| |||||
| Pre/Post exercise muscle strength | 78.1 + 25.9 | 92.2 + 26.1 | 85.0 + 34.1 | 90.6 + 19.3 | |
| Change of muscle strength | 11.5 ± 26.9 | 1.4 ± 27.2 | 0.204 | ||
|
| |||||
| Pre/Post exercise muscle strength | 75.5 + 19.4 | 87.5 + 28.2 | 70.5 + 24.7 | 71.9 + 32.7 | |
| Change of muscle strength | 12.0 ± 26.4 | 10.2 ± 26.3 | 0.811 | ||
|
| |||||
| Pre/Post exercise muscle strength | 109.1 + 37.7 | 122.2 + 40.5 | 116.1 + 43.5 | 130.7 + 41.5 | |
| Change of muscle strength | 21.7 ± 48.4 | 3.9 ± 31.0 | 0.153 | ||
|
| |||||
|
| |||||
| Pre/Post exercise muscle endurance | 85.3 + 65.4 | 106.9 + 38.8 | 102.5 + 53.9 | 105.1 + 42.6 | |
| Change of muscle endurance | 18.8 ± 43.6 | −5.6 ± 33.1 | 0.038 | ||
|
| |||||
| Pre/Post exercise muscle endurance | 65.1 + 65.4 | 62.1 + 17.4 | 58.8 + 25.2 | 66.5 + 18.1 | |
| Change of muscle endurance | −5.2 ± 61.9 | 4.2 ± 20.1 | 0.517 | ||
|
| |||||
| Pre/Post exercise muscle endurance | 63.0 + 21.0 | 70.9 + 24.0 | 64.8 + 23.0 | 66.5 + 18.1 | |
| Change of muscle endurance | 7.9 ± 25.6 | 3.1 ± 14.3 | 0.449 | ||
|
| |||||
| Pre/Post exercise muscle endurance | 79.3 + 36.3 | 89.3 + 29.9 | 82.4 + 30.4 | 89.1 + 36.2 | |
| Change of muscle endurance | 10.0 ± 32.2 | 5.7 ± 27.7 | 0.624 | ||
Logistic regression analysis to predict post-exercise 12 week continent status.
| Univariate | Multivariate | |||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | 0.897 | 0.994 (0.901–1.096) | 0.686 | 0.965 (0.811–1.148) |
| BMI | 0.354 | 0.943 (0.833–1.067) | 0.800 | 0.963 (0.719–1.289) |
| Prostate volume | 0.822 | 0.997 (0.968–1.026) | 0.454 | 0.984 (0.942–1.027) |
| Pathologic T stage | 0.293 | 0.550 (0.181–1.675) | 0.773 | 1.369 (0.162–11.535) |
| Operative Methods | 0.983 | 0.988 (0.330–2.962) | 0.553 | 1.811 (0.280–11.703) |
| MUCP | 0.045 | 1.031 (1.001–1.061) | 0.097 | 1.046 (0.992–1.103) |
| Change of hip extensor muscle strength (Nm) | 0.010 | 1.029 (1.007–1.053) | 0.045 | 1.039 (1.001–1.080) |
BMI, Body mass index; RRP, retropubic radial prostatectomy; RALP, robot-assisted laparoscopic radical prostatectomy; MUCP, Maximal urethra closure pressure.